Target Price | $13.20 |
Price | $8.01 |
Potential |
64.79%
register free of charge
|
Number of Estimates | 5 |
5 Analysts have issued a price target Theravance Biopharma Inc 2025 .
The average Theravance Biopharma Inc target price is $13.20.
This is
64.79%
register free of charge
$21.00
162.17%
register free of charge
$9.00
12.36%
register free of charge
|
|
A rating was issued by 5 analysts: 2 Analysts recommend Theravance Biopharma Inc to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Theravance Biopharma Inc stock has an average upside potential 2025 of
64.79%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 57.42 | 60.93 |
11.82% | 6.12% | |
Net Margin | -85.20% | -57.37% |
75.50% | 32.66% |
3 Analysts have issued a sales forecast Theravance Biopharma Inc 2024 . The average Theravance Biopharma Inc sales estimate is
This results in the following potential growth metrics:
5 Theravance Biopharma Inc Analysts have issued a net profit forecast 2024. The average Theravance Biopharma Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.00 | -0.71 |
72.60% | 29.00% | |
P/E | negative | |
EV/Sales | 5.62 |
5 Analysts have issued a Theravance Biopharma Inc forecast for earnings per share. The average Theravance Biopharma Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Theravance Biopharma Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Theravance Biopharma Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.